TD Cowen Trims Molina Healthcare (NYSE:MOH) Target Price to $412.00

Molina Healthcare (NYSE:MOH - Free Report) had its target price trimmed by TD Cowen from $453.00 to $412.00 in a research note published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other brokerages have also recently weighed in on MOH. StockNews.com cut shares of Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Wells Fargo & Company decreased their price objective on Molina Healthcare from $410.00 to $375.00 and set an equal weight rating for the company in a research note on Monday. Stephens reaffirmed an equal weight rating and issued a $390.00 target price on shares of Molina Healthcare in a report on Thursday, April 25th. Cantor Fitzgerald reiterated an overweight rating and set a $406.00 price target on shares of Molina Healthcare in a report on Thursday, April 4th. Finally, Barclays reduced their price objective on shares of Molina Healthcare from $437.00 to $430.00 and set an equal weight rating on the stock in a report on Thursday, April 25th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Molina Healthcare presently has a consensus rating of Hold and a consensus price target of $398.55.

Molina Healthcare Trading Down 0.5 %

MOH traded down $1.79 during trading hours on Tuesday, reaching $342.10. The company's stock had a trading volume of 390,458 shares, compared to its average volume of 402,951. The business's 50-day moving average is $387.99 and its 200-day moving average is $372.33. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a market cap of $20.05 billion, a PE ratio of 18.56, a P/E/G ratio of 0.96 and a beta of 0.47. Molina Healthcare has a fifty-two week low of $266.35 and a fifty-two week high of $423.92.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts' consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business had revenue of $9.93 billion during the quarter, compared to analysts' expectations of $9.45 billion. During the same period in the prior year, the business posted $5.81 EPS. The company's revenue was up 21.9% compared to the same quarter last year. As a group, equities research analysts predict that Molina Healthcare will post 23.62 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In other news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company's stock, valued at $14,121,423.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard M. Schapiro sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now directly owns 11,207 shares of the company's stock, valued at $4,494,567.35. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock valued at $6,472,517 in the last three months. 1.11% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in MOH. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in Molina Healthcare in the third quarter valued at $30,000. McIlrath & Eck LLC acquired a new position in Molina Healthcare during the fourth quarter worth about $34,000. VisionPoint Advisory Group LLC increased its holdings in Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company's stock valued at $36,000 after buying an additional 57 shares in the last quarter. Raleigh Capital Management Inc. increased its holdings in Molina Healthcare by 40.4% in the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company's stock valued at $41,000 after buying an additional 36 shares in the last quarter. Finally, Principal Securities Inc. acquired a new stake in shares of Molina Healthcare during the 4th quarter valued at approximately $42,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.